Trial Profile
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2014
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 05 Nov 2014 New trial record